21:57 , Dec 15, 2017 |  BioCentury  |  Product Development

Patient-powered precision

The Harvard Business School’s Kraft Precision Medicine Accelerator is tackling a series of initiatives that will position patients to help drive improvements in both clinical care and clinical research. The accelerator was founded in 2015 with...
07:00 , Oct 13, 2016 |  BC Innovations  |  Strategy

Exosomes in the zone

Mark Zipkin, Staff Writer  Having had a slow on-ramp to recognition as more than cellular garbage bags, exosomes are gaining status as a potentially transformational technology, with utility in both diagnostics and therapeutics. But the field...
07:00 , Sep 5, 2016 |  BioCentury  |  Strategy

Back to School: Haste, not waste

As researchers in industry and academia rapidly unravel molecular disease mechanisms and drug developers become more adept at intervening in disease pathways with drugs targeted to specific populations, the current clinical development paradigm cannot keep...
08:00 , Feb 13, 2012 |  BC Week In Review  |  Company News

Exosome Diagnostics, Accelerate Brain Cancer Cure deal

Exosome and the not-for-profit partnered with academic medical centers to develop Exosome's RNA blood and cerebrospinal fluid-based molecular diagnostic technology for early identification, progression monitoring and disease risk stratification in glioma. The technology detects disease-specific...
07:00 , Oct 24, 2005 |  BC Week In Review  |  Company News

Genentech, Accelerate Brain Cancer Cure deal

DNA and the not-for-profit organization will collaborate to study DNA's Avastin bevacizumab in glioblastoma multiforme (GBM). Initially, the parties will study dynamic contrast enhancement images from GBM patients receiving Avastin in a Phase II...
07:00 , May 30, 2005 |  BioCentury  |  Finance

Venture philanthropists

Venture philanthropists Organization Focus Founded Founder/ Founding family Funds/yr Accelerate Brain Cancer Cure Brain cancer 2001 Dan and Steve Case and their families $1.0 Bill and Melinda Gates Foundation Infectious diseases; HIV/AIDS; tuberculosis; reproductive...
07:00 , May 30, 2005 |  BioCentury  |  Finance

VPOs into the breach

Biotech startups have been complaining that the venture community is less willing to fund very early stage technologies than in the past. As a result, there is a gap between academic discoveries and the translational...
07:00 , Oct 4, 2004 |  BC Week In Review  |  Company News

CombinatoRx, Accelerate Brain Cancer Cure, Duke University deal

CombinatoRx will use its combination high throughput screening (cHTS) platform to identify combination products that hit multiple targets relevant to treating glioblastoma multiforme (GBM). The university will provide research materials and preclinical assessment of products....
08:00 , Mar 4, 2002 |  BC Week In Review  |  Company News

Genentech, Accelerate Brain Cancer Cure deal

DNA and Accelerate, a non-profit foundation started by former H&Q Chairman and CEO Dan Case and AOL/Time Warner Chairman Steve Case, partnered to develop therapies to treat brain cancer. The foundation will share development expenses...
08:00 , Feb 25, 2002 |  BC Extra  |  Company News

Genentech, Accelerate cancer deal

DNA and Accelerate Brain Cancer Cure, a non-profit foundation started by former H&Q Chairman and CEO Dan Case and AOL/Time Warner Chairman Steve Case, partnered to develop therapies to treat brain cancer. The foundation will...